tradingkey.logo

Trinity Biotech PLC

TRIB
0.990USD
+0.004+0.44%
Market hours ETQuotes delayed by 15 min
8.21MMarket Cap
LossP/E TTM

Trinity Biotech PLC

0.990
+0.004+0.44%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Trinity Biotech PLC

Currency: USD Updated: 2025-11-04

Key Insights

The company's fundamentals are relatively weak. Its valuation is considered fairly valued,and institutional recognition is very high. Despite a weak stock market performance, the company shows strong fundamentals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Trinity Biotech PLC's Score

Industry at a Glance

Industry Ranking
158 / 210
Overall Ranking
458 / 4616
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 0 analysts
--
Current Rating
--
Target Price
--
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Trinity Biotech PLC Highlights

StrengthsRisks
Trinity Biotech plc is an Ireland-based commercial stage biotechnology company. The Company is focused on human diagnostics and diabetes management solutions, including wearable biosensors. The Company develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market and has also entered the wearable biosensor industry. It intends to develop a range of biosensor devices and related services, starting with a continuous glucose monitoring product. Its products are used to detect infectious diseases and to quantify the level of Hemoglobin A1c and other chemistry parameters in serum, plasma and whole blood. The Company, through EpiCapture Limited, is also developing a non-invasive test for monitoring the risk of aggressive prostate cancer. The Company sells its products direct in the United States and through a network of international distributors.
Growing
The company is in a growing phase, with the latest annual income totaling USD 61.55M.
Fairly Valued
The company’s latest PE is -0.19, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 969.66K shares, increasing 42.50% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 11.39K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 8.62.

Financial Health

Currency: USD Updated: 2025-11-04

The company's current financial score is 6.48, which is lower than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 15.15M, representing a year-over-year increase of 3.24%, while its net profit experienced a year-over-year increase of 29.19%.

Score

Industry at a Glance

Previous score
6.48
Change
0

Financials

3.45

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data

Quality of Earnings

7.97

Operational Efficiency

7.19

Growth Potential

6.67

Shareholder Returns

7.13

Trinity Biotech PLC's Company Valuation

Currency: USD Updated: 2025-11-04

The company’s current valuation score is 6.90, which is lower than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is -0.19, which is -47.97% below the recent high of -0.10 and -176.78% above the recent low of -0.54.

Score

Industry at a Glance

Previous score
6.90
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 158/210
No Data

Earnings Forecast

Currency: USD Updated: 2025-11-04

There is no earnings forecast score for this company; the Healthcare Equipment & Supplies industry's average is 7.74.

Score

Industry at a Glance

Previous score
0.00
Change
0

Support & Resistance

No Data
No Data

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-04

The company’s current price momentum score is 5.51, which is lower than the Healthcare Equipment & Supplies industry's average of 6.77. Sideways: Currently, the stock price is trading between the resistance level at 1.15 and the support level at 0.86, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.00
Change
-0.49

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(1)
Neutral(5)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
0.011
Neutral
RSI(14)
45.933
Neutral
STOCH(KDJ)(9,3,3)
51.333
Neutral
ATR(14)
0.072
Low Volatility
CCI(14)
-11.779
Neutral
Williams %R
45.045
Neutral
TRIX(12,20)
-0.544
Sell
StochRSI(14)
100.000
Buy
Moving Average
Sell(4)
Neutral(0)
Buy(2)
Indicators
Value
Direction
MA5
0.995
Sell
MA10
0.984
Buy
MA20
1.017
Sell
MA50
1.124
Sell
MA100
1.000
Sell
MA200
0.861
Buy

Institutional Confidence

Currency: USD Updated: 2025-11-04

The company’s current institutional recognition score is 3.00, which is lower than the Healthcare Equipment & Supplies industry's average of 6.39. The latest institutional shareholding proportion is 12.89%, representing a quarter-over-quarter decrease of 24.13%. The largest institutional shareholder is James Simons, holding a total of 11.39K shares, representing 0.31% of shares outstanding, with 70.96% decrease in holdings.

Score

Industry at a Glance

Previous score
3.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
Perceptive Advisors LLC
358.00K
--
Hunter Associates Investment Management LLC
87.58K
+16.74%
MiCo IVD Holdings, LLC
447.59K
--
Moss Adams Wealth Advisors LLC
5.13K
--
Whitefort Capital Management, LP
16.38K
--
Williams & Novak Wealth Management, LLC
4.40K
+20.88%
Renaissance Technologies LLC
Star Investors
11.39K
-25.70%
Inspirion Wealth Advisors, LLC
10.00K
+400.00%
Highbridge Capital Management, LLC
6.75K
--
1
2

Risk Assessment

Currency: USD Updated: 2025-11-04

The company’s current risk assessment score is 1.21, which is lower than the Healthcare Equipment & Supplies industry's average of 4.57. The company's beta value is 0.50. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Score

Industry at a Glance

Previous score
1.21
Change
0
Beta vs S&P 500 index
0.50
VaR
+7.73%
240-Day Maximum Drawdown
+61.76%
240-Day Volatility
+164.94%

Return

Best Daily Return
60 days
+89.05%
120 days
+89.05%
5 years
+89.05%
Worst Daily Return
60 days
-15.18%
120 days
-15.18%
5 years
-29.92%
Sharpe Ratio
60 days
+0.95
120 days
+0.98
5 years
-0.19

Risk Assessment

Maximum Drawdown
240 days
+61.76%
3 years
+91.18%
5 years
+98.43%
Return-to-Drawdown Ratio
240 days
-0.37
3 years
-0.30
5 years
-0.19
Skewness
240 days
+5.32
3 years
+4.50
5 years
+4.40

Volatility

Realised Volatility
240 days
+164.94%
5 years
+126.94%
Standardised True Range
240 days
+9.65%
5 years
+48.53%
Downside Risk-Adjusted Return
120 days
+317.37%
240 days
+317.37%
Maximum Daily Upside Volatility
60 days
+500.23%
Maximum Daily Downside Volatility
60 days
+145.13%

Liquidity

Average Turnover Rate
60 days
+3.79%
120 days
+1.93%
5 years
--
Turnover Deviation
20 days
+861.59%
60 days
+284.98%
120 days
+95.76%

Peer Comparison

Healthcare Equipment & Supplies
Trinity Biotech PLC
Trinity Biotech PLC
TRIB
4.18 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Castle Biosciences Inc
Castle Biosciences Inc
CSTL
8.67 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cencora Inc
Cencora Inc
COR
8.60 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
AxoGen Inc
AxoGen Inc
AXGN
8.58 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
TCMD
8.57 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings Inc
ZBH
8.54 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI